Gabriela Gruia Aprea Therapeutics, Inc. (APRE) insider trading activity

APRE Quotes by TradingView

Gabriela Gruia is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 1,045 shares of APRE, which is worth approximately $1,734. The most recent transaction as insider was on Jun 05, 2025, when has been sold 1,045 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.05K
n/a 3M change
n/a 12M change
Total Value Held $1,734

Gabriela Gruia Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2025
BUY
Grant, award, or other acquisition
-
1,045 Added 50.0%
1,045 Common Stock

Also insider at

TCRX
TScan Therapeutics, Inc. Healthcare
MTEM
Molecular Templates, Inc. Healthcare
GG

Gabriela Gruia

Director
Waltham, MA

Track Institutional and Insider Activities on APRE

Follow Aprea Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APRE shares.

Notify only if

Insider Trading

Get notified when an Aprea Therapeutics, Inc. insider buys or sells APRE shares.

Notify only if

News

Receive news related to Aprea Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APRE